COMMUNIQUÉS West-GlobeNewswire
-
Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion
28/10/2026 -
Actinogen pivotal Alzheimer’s disease trial database lock milestone - topline results on track for mid-November
28/10/2026 -
OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
28/10/2026 -
Houston VA Study Reports Increased Quantitative Monitoring with TwitchView®; Separate Study Shows Near-Zero Bias Versus Gold Standard Mechanomyography, Both Presented at ANESTHESIOLOGY® 2026
28/10/2026 -
Biosphere Secures $21 Million Department of War Contract for Biomanufacturing of Critical Chemicals
28/10/2026 -
LiveWorld Appoints Rema Judeh as Vice President of Account Management
28/10/2026 -
Arcutis Appoints Rob Scott, MD to Board of Directors
28/10/2026 -
Nelipak Healthcare Packaging Awarded Silver Medal Sustainability Rating from EcoVadis
28/10/2026 -
Manta Cares and Cancer Support Community SF Bay Area Partner to Bring AI-Powered Cancer Support to Northern California Patients and Families
28/10/2026 -
HealthCore Foundation Announces Nearly $250 Million Real Estate Transaction with Northbay Health to Support Outpatient Expansion in Northern California
28/10/2026 -
Nacuity Pharmaceuticals Announces First Patient Dosed in Global Confirmatory Phase 3 Trial of NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa Associated with Usher Syndrome
28/10/2026 -
Athelas Named Diamond Sponsor of the 2026 APTA Private Practice Annual Conference, Deepening Its Commitment to the Physical Therapy Profession
28/10/2026 -
Digital Wellness Launches Protein Calculator for Mayo Clinic Diet to End the Guesswork Around Daily Protein Needs
28/10/2026 -
Longeveron Announces Engagement of Lucid Capital Markets
28/10/2026 -
Vivex Biologics' VIA Disc® NP Meets Primary Endpoint in Pivotal, Sham-Controlled ASCEND Trial Published in Journal of Clinical Medicine
28/10/2026 -
Applied Biologics Announces Publication of Peer-Reviewed CAMPX Interim Trial Results in the Journal of Chronic Wound Care Management & Research
28/10/2026 -
Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer
28/10/2026 -
DoStance App Launches Personalized Posture App With Guided Daily Exercises
28/10/2026 -
New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits
28/10/2026
Pages